Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 12.39
-1.04 %
$ 1.13 B
Market Cap
-9.68
P/E
MYGN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities MYGN - Myriad Genetics, Inc.
31.9 M
LAST VALUE
-65.90%
2 YEAR CAGR
16.12%
5 YEAR CAGR
14.30%
10 YEAR CAGR